Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 3/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.35 |
| ▸ | TNKS | O95271 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16905656 | 0.88 | KDM4E (0.39) | IDO1SLC6A4MCL1ARTNKS | |
| SCHEMBL13564568 | 0.83 | IDO1 (0.42) | IDO1MAOBTDO2SLC6A4DYRK1A | |
| SCHEMBL29623029 | 0.81 | IDO1 (0.40) | IDO1MAOBTDO2SLC6A4AR | |
| SCHEMBL22315719 | 0.81 | IDO1 (0.50) | IDO1TDO2SLC6A4DYRK1ATNKS | |
| SCHEMBL31672685 | 0.81 | IDO1 (0.50) | IDO1TDO2SLC6A4DYRK1ATNKS | |
| SCHEMBL20402953 | 0.81 | IDO1 (0.48) | IDO1MAOBTDO2ARDYRK1A | |
| SCHEMBL18347524 | 0.79 | IDO1 (0.47) | IDO1MAOBTDO2SLC6A4AR | |
| SCHEMBL31355175 | 0.79 | IDO1 (0.48) | IDO1TDO2DYRK1ATNKSCA1 | |
| SCHEMBL14565445 | 0.78 | CYP1A2 (0.46) | MAOBMCL1DYRK1A | |
| SCHEMBL548396 | 0.77 | IDO1 (0.45) | IDO1MAOBTDO2HSD17B3TNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11785839-B2 | Organic light-emitting materials containing cyano-substituted ligand | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-10-10 | — | — | US | disclosed |
| US-10367151-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-30 | — | — | US | disclosed |
| US-20160380210-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160380210-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNT1 | IDO1 2704/4885MAOB 2568/4885TDO2 2961/4885 |
| US-11785839-B2 | Organic light-emitting materials containing cyano-substituted ligand | L1CAM, CYBA, ICOSLG | IDO1 2002/4885MAOB 1032/4885TDO2 2076/4885 |
| US-10367151-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CRY2, CCNE2 | IDO1 2528/4885MAOB 2890/4885TDO2 2911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.